Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial)

behalf of the KAICA Trial investigators

衛生学公衆衛生学

研究成果: Article › 査読

フィンガープリント

「Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial)」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

並べ替え順
重み付け
アルファベット順

Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial)

フィンガープリント

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science